10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,257,762 | +280.0% | 22,436 | +210.1% | 0.00% | – |
| Q2 2022 | $331,000 | -30.3% | 7,235 | +15.9% | 0.00% | -100.0% |
| Q1 2022 | $475,000 | -86.9% | 6,241 | -74.2% | 0.00% | -66.7% |
| Q4 2021 | $3,616,000 | +33.0% | 24,202 | +30.2% | 0.00% | 0.0% |
| Q3 2021 | $2,719,000 | -66.8% | 18,587 | -55.6% | 0.00% | -66.7% |
| Q2 2021 | $8,202,000 | -13.4% | 41,857 | -20.1% | 0.01% | -18.2% |
| Q1 2021 | $9,469,000 | +834.7% | 52,356 | +631.8% | 0.01% | +1000.0% |
| Q4 2020 | $1,013,000 | – | 7,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |